Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juli 2022

Genmab — Juli 2022

Planlagt Fastgjort Låst Flyttet Genmab
808 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    Doublo
    wrote on sidst redigeret af
    #673

    God morgen 🙂 Ja og udover den dejlige stigning på Genmab har der endelig været lidt positiv bevægelse i A.P. Møller som jeg desværre/heldigvis? har en hulens masse af!!

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #674

      Historisk Vinge( gaard) sus. 😄

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #675

        Ja, det var flot bibob;-)

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #676

          the Japanese Epcoritamab trial starts recruiting again, with a few additional arms added https://www.clinicaltrials.gov/ct2/history/NCT04542824?A=5&B=6&C=merged#StudyPageTop

          1 Reply Last reply
          0
          • bongobobB Offline
            bongobobB Offline
            bongobob
            wrote on sidst redigeret af
            #677

            Thanks EL. Apparently Genmab has 21 investigational sites in Japan. Is that with staff or just agreements with clinics

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #678

              no, they are all hospitals; you can see that in the earlier version they mentioned the names of the hospitals. I don't know why they changed it to read like this , but have seen it in more trials with other companies also

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #679

                Akter/middag: Bavarian rykker på godkendelse - banker kommer lidt igen https://www.proinvestor.com/investornyt/854869/akter-middag-bavarian-rykker-pa-godkendelse-banker-kommer-lidt-igen

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #680

                  Ofatumumab forbedrer RMS-patienters kognition https://mstidsskrift.dk/37-sygdom/767-ofatumumab-forbedrer-rms-patienters-kognition.html

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #681

                    "Medicinske tidsskrifter har tidligere beskrevet, hvorvidt studiet har konkluderet, at ofatumumab viser en bedre effekt på attakker og disability end teriflunomid".

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #682

                      Tak Bulder. 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #683

                        Transactions in connection with share buy-back program https://www.proinvestor.com/investornyt/854921/transactions-in-connection-with-share-buy-back-program

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          deleted-user
                          wrote on sidst redigeret af
                          #684

                          Fra 72.000 til 18.000 aktier tilbagekøbt på ugebasis. Sommeren er over os 🙂

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            lahn1
                            wrote on sidst redigeret af
                            #685

                            Hvem er ham James Bond med butterfly på forsiden ? 😉

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #686

                              Godmorgen. 🙂

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #687

                                lahn...Jeg er klædt på til lejligheden. Det er altid en fest at være på PI. 🙂

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Stroka
                                  wrote on sidst redigeret af
                                  #688

                                  God morgen. 🙂

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #689

                                    Genmab/BMO: Hæver kursmålet med over 100 kr.
                                    https://www.proinvestor.com/investornyt/855348/genmab-bmo-haever-kursmalet-med-over-100-kr

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #690

                                      Tak for den og god morgen;-)

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #691

                                        God morgen. 🙂

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bibob
                                          wrote on sidst redigeret af
                                          #692

                                          https://www.onclive.com/view/teclistamab-approaches-eu-approval-for-relapsed-refractory-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=07252022_OncLive_SAN-22-OSD1317_MM CC_Sanofi_Sarclisa_GLOBAL&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==
                                          Teclistamab.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper